Sort by
Neuroscience
Placebo
100%
Pervasive Developmental Disorder
45%
Magnetic Resonance Imaging
45%
Brain Function
45%
Serotonin Transporter
45%
Agonist
45%
Dopamine Antagonist
45%
Crossover Study
45%
Autism
45%
Gamma-Aminobutyric Acid
45%
Serotonin
38%
Arbaclofen
27%
Aripiprazole
25%
Citalopram
19%
Receptor
19%
Functional Connectivity
19%
Amisulpride
19%
Hippocampus
15%
Lateral Ventricle
15%
Nerve Cell Differentiation
15%
Circadian Rhythm
15%
Dopamine Receptor D2
12%
Anterior Cingulate Cortex
12%
Antipsychotic
12%
Striatum
12%
Thalamus
12%
Serotonergic
12%
Functional Magnetic Resonance Imaging
12%
Sensory Processing
9%
4 Aminobutyric Acid B Receptor
9%
Cognitive Function
9%
Limbic System
9%
Receptor Agonists
9%
Positron Emission Tomography
6%
In Vivo
6%
5-HT4 Receptor
6%
Brain Network
6%
Face
6%
Ventromedial Prefrontal Cortex
6%
DNA Template
6%
Serotonin Reuptake Inhibitor
6%
Glutamic Acid
6%
Receptor Partial Agonist
6%
Nuclear Magnetic Resonance Spectroscopy
6%
Blood Plasma
6%
Receptor Antagonist
6%
Glutamine
6%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
45%
Partial Agonist
45%
Normal Human
45%
Dopamine Receptor Blocking Agent
45%
Aripiprazole
30%
Amisulpride
22%
Antipsychotic
15%
Placebo-Controlled Study
7%
Glutamic Acid
7%
Glutamine
7%
Dopamine 2 Receptor Blocking Agent
7%
Dopamine Receptor D2
7%
Active Metabolite
7%